Login
Toggle navigation
Videos
Categories
Trending
Get to know Erica Yount of Modera Wealth Management, LLC
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tom Orecchio, CFA, CFP - Chief Executive Officer - Modera Wealth Management
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
From Italy to Global Leadership: The Journey of Fabrizio Freda | Fabrizio Freda, CEO, The Estée Lauder Companies Inc.
00:10:00
Building a Resilient Balance Sheet for a Stronger Future | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
Proprietary Nano Polymer Technology Poised to Revolutionize Clean Energy and Life Sciences Sectors, Targeting First Revenues|David Radford, CEO, Anteotech Ltd.
00:10:00
Navigating Utility Leadership and Customer Choice Amid Regulatory Changes and Environmental Challenges | Sean Trauschke, CEO, OGE Energy Corp.
00:10:00
Cooling Inflation and Economic Resiliency - David and Rusty | Hilltop Wealth Advisors
00:10:00
2024 Market Outlook: JNBA Experts Discuss Trends and Strategies | Richard S. Brown - CHAIRMAN & CHIEF EXECUTIVE OFFICER of JNBA Financial Advisors
00:10:00
DEUTZ HV2023: CEO Sebastian Schulte's Address | Dr. Sebastian C. Schulte - CEO of DEUTZ AG
00:10:00
Guaranteeing Assured Quality of Service for Telecom Customers | Jerry Li, CEO, PCCW Ltd8:HKG
00:10:00
"Challenges and Prospects in the UK Sales Storage Market: Navigating Surplus Capacity and Development Finance Constraints"|CEO ,Big Yellow Group PLC
00:10:00
Deciding When and How to Sell Your Business with Mentor Securities
00:10:00
"Artur Popko, President of the Management Board at Budimex SA, presents company results to investors on inwestorzy.tv."|Artur Popko, President of the Management Board at Budimex SA
00:10:00
Closing the gender gap in VC funding|Eve Burton,Chairwoman HearstLab,HearstLab